Abstract
Background
Study Design
Results
Conclusion
Keywords
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to ContraceptionReferences
UNAIDS. AIDS epidemic update. http://www.unaids.org/en/KnowledgeCentre/HIVData/EpiUpdate/EpiUpdArchive/2009/default.asp.
http://www.healthypeople.gov/Data/midcourse/html/focusareas/FA09Introduction.htm.
- Disparities in rates of unintended pregnancy in the United States, 1994 and 2001.Perspect Sex Reprod Health. 2006; 38: 90-96
- HPTN 055 Study Team. The value of site preparedness studies for future implementation of phase 2/IIb/III HIV prevention trials: experience from the HPTN 055 study.J Acquir Immune Defic Syndr. 2008; 47: 93-100
- A little bit pregnant: modeling how the accurate detection of pregnancy can improve HIV prevention trials.Am J Epidemiol. 2009; 4: 515-521
- Overview of methodological challenges in HIV prevention trials.in: IOM Committee on Methodological Challenges in HIV Prevention Trials. Public Meeting. Washington, D.C., February 6���72007
- Estimates of contraceptive failure from the 2002 National Survey of Family Growth.Contraception. 2008; 77: 10-21
Karim SA, Coletti A, Richardson B, et al. Safety and effectiveness of vaginal microbicides BufferGel and 0.5% PRO 2000/5 gel for the prevention of HIV Infection in women: results of the HPTN 035 trial. CROI 2009, Montreal, Canada, February 2009.
United States Department of Health and Human Services, National Center for Health Statistics. National Survey of Family Growth, Cycle VI, 2002. ICPSR04157-v1. Ann Arbor (Mich): Institute for Social Research, 2004. Ann Arbor (Mich): Inter-university Consortium for Political and Social Research, 2008-10-01. doi:10.3886/ICPSR04157.
- Defining dimensions of pregnancy intendedness.Matern Child Health J. 2000; 4: 183-189
- Counseling in the clinical setting to prevent unintended pregnancy: an evidence-based research agenda.Contraception. 2003; 67: 115-132
- Predictors of dual method use for pregnancy and HIV prevention among adolescent South African women.Contraception. 2007; 75: 383-389
- Determinants of contraceptive method among young women at risk for unintended pregnancy and sexually transmitted infections.Contraception. 2003; 68: 19-25
- Protecting against both pregnancy and disease: predictors of dual method use among a sample of women.Women's Health. 2004; 39: 25-43
- Dual method use in adolescents: a review and framework for research in use of STD and pregnancy protection.J Adolesc Health. 2003; 32: 340-349
- Pregnancy prevention practices among women with multiple partners in an HIV prevention trial.J Acquir Immune Defic Syndr. 2007; : 32-38
- A simulation study of the number of events per variable in logistic regression analysis.J Clin Epidemiol. 1996; 49: 1373-1379
- Unintended pregnancy in the United States.Fam Plann Perspect. 1998; 30: 24-29
Article info
Publication history
Footnotes
���This study was funded by the University of Pennsylvania Center for AIDS Research Pilot Grant Program.
������HPTN 035 was funded by the US National Institutes of Health (NIH). The study was designed and implemented by the HIV Prevention Trials Network (HPTN) and by the Microbicide Trials Network (MTN). The HPTN (U01AI46749) has been funded by the National Institute of Allergy and Infectious Diseases (NIAID), National Institute of Child Health and Development (NICHD), National Institute of Drug Abuse (NIDA) and National Institute of Mental Health (NIMH). The MTN (U01AI068633) has been funded by NIAID, NICHD and NIMH. The study products were provided free of charge by Indevus Pharmaceuticals, Inc., and by ReProtect, Inc. The US Agency for International Development (USAID) provided funding for manufacturing of BufferGel for this study.
